Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

K.-D. Kang; J.D. Bernstock; S.K. Totsch; S.E. Gary; A. Rocco; L. Nan; R. Li; T. Etminan; X. Han; E.A. Beierle; T. Eisemann; R.J. Wechsler-Reya; S. Bae; R. Whitley; G.Y. Gillespie; J.M. Markert; G.K. Friedman

doi:10.1158/1078-0432.CCR-22-1382

Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

K.-D. Kang
, J.D. Bernstock
, S.K. Totsch
, S.E. Gary
, A. Rocco
, L. Nan
, R. Li
, T. Etminan
, X. Han
, E.A. Beierle
, T. Eisemann
, R.J. Wechsler-Reya
, S. Bae
, R. Whitley
, G.Y. Gillespie
, J.M. Markert
, G.K. Friedman

Biostatistics, Data Science, & Epidemiology

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Original language	Undefined
Journal	Clinical Cancer Research
DOIs	https://doi.org/10.1158/1078-0432.CCR-22-1382
State	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1158/1078-0432.CCR-22-1382

Cite this

Kang, K.-D., Bernstock, J. D., Totsch, S. K., Gary, S. E., Rocco, A., Nan, L., Li, R., Etminan, T., Han, X., Beierle, E. A., Eisemann, T., Wechsler-Reya, R. J., Bae, S., Whitley, R., Gillespie, G. Y., Markert, J. M., & Friedman, G. K. (2022). Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-22-1382

Kang, K-D, Bernstock, JD, Totsch, SK, Gary, SE, Rocco, A, Nan, L, Li, R, Etminan, T, Han, X, Beierle, EA, Eisemann, T, Wechsler-Reya, RJ, Bae, S, Whitley, R, Gillespie, GY, Markert, JM & Friedman, GK 2022, 'Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers', Clinical Cancer Research. https://doi.org/10.1158/1078-0432.CCR-22-1382

@article{63ff54c926724d8da90c8f8894063577,

title = "Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers",

author = "K.-D. Kang and J.D. Bernstock and S.K. Totsch and S.E. Gary and A. Rocco and L. Nan and R. Li and T. Etminan and X. Han and E.A. Beierle and T. Eisemann and R.J. Wechsler-Reya and S. Bae and R. Whitley and G.Y. Gillespie and J.M. Markert and G.K. Friedman",

year = "2022",

doi = "10.1158/1078-0432.CCR-22-1382",

language = "Undefined",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

AU - Kang, K.-D.

AU - Bernstock, J.D.

AU - Totsch, S.K.

AU - Gary, S.E.

AU - Rocco, A.

AU - Nan, L.

AU - Li, R.

AU - Etminan, T.

AU - Han, X.

AU - Beierle, E.A.

AU - Eisemann, T.

AU - Wechsler-Reya, R.J.

AU - Bae, S.

AU - Whitley, R.

AU - Gillespie, G.Y.

AU - Markert, J.M.

AU - Friedman, G.K.

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/inward/record.url?eid=2-s2.0-85144588376&partnerID=MN8TOARS

U2 - 10.1158/1078-0432.CCR-22-1382

DO - 10.1158/1078-0432.CCR-22-1382

M3 - Article

SN - 1078-0432

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -

Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers

UN SDGs

Access to Document

Other files and links

Cite this